Chief Commercial Officer
Chris Grimes-Crompton joined Steba with a background of over 20 years in the life sciences industry. He has enjoyed a variety of roles at increasingly senior levels including Market Access Corporate Affairs and Global Commercialization. He brings a wealth of experience in managing product franchises across multiple disease areas and in advancing (Phi-III) and launching products across the world. He has an established track record in developing & implementing franchise strategies and in building agile organisations and structures to optimise success. He will play an important role in Steba as we launch our first Commercial Indications for Prostate Cancer in Europe and build our clinical pipeline in other indications with our unique proprietary platform.